Maria Luisa Guerrera

8PUBLICATIONS
24CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyHaematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 08, 2026
WNK2 oncogenicity revealed by the discovery and functional characterization of novel gene isoforms in MYD88 mutated Waldenström's Macroglobulinemia.

|Mar 15, 2026
Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia.

Jorge J Castillo, Andrew R Branagan, Alberto Guijosa

|Feb 11, 2026
Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia.

Hao Sun, Romanos Sklavenitis Pistofidis, Shirong Liu

|Oct 21, 2025
Familial clusters and clinical features, complications, and outcomes in 1000 patients with Waldenström macroglobulinemia.

Andres Ramirez-Gamero, Nicholas Tsakmaklis, Zachary R Hunter

|Nov 16, 2023
Ibrutinib and venetoclax as primary therapy in symptomatic, treatment-naïve Waldenström macroglobulinemia.

Jorge J Castillo, Andrew R Branagan, David Sermer

Pageof 2

Frequent Collaborators

8 joint publications

Jorge J Castillo

8 joint publications

Zachary R Hunter

8 joint publications

Steven P Treon

7 joint publications

Andrew R Branagan